# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-22-257589
Filing Date
2022-10-04
Accepted
2022-10-04 16:07:24
Documents
15
Period of Report
2022-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d397743d8k.htm iXBRL | 8-K | 62296
2 | EX-4.1 | d397743dex41.htm | EX-4.1 | 938344
3 | EX-4.2 | d397743dex42.htm | EX-4.2 | 971227
4 | EX-4.3 | d397743dex43.htm | EX-4.3 | 626230
| Complete submission text file | 0001193125-22-257589.txt |  | 3293573

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | bhc-20220930.xsd | EX-101.SCH | 2534
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bhc-20220930_lab.xml | EX-101.LAB | 18798
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bhc-20220930_pre.xml | EX-101.PRE | 11779
9 | EXTRACTED XBRL INSTANCE DOCUMENT | d397743d8k_htm.xml | XML | 3498

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 221291548
SIC: 2834 Pharmaceutical Preparations